Back to Agenda
Closing
Speaker(s)
Sara Torgal, MPHARM
Global Regulatory Policy Lead, DIA, Switzerland
Closing Remarks
Mats G. Hansson
IMI PREFER Coordinator & Senior Professor of Biomedical Ethics, Uppsala University, Sweden
Closing Remarks
Conny Berlin, MS
IMI PREFER Project Leader & Global Head, Quantitative Safety and Epidemiology, Novartis Pharma AG, Switzerland
Closing Remarks
Have an account?